Assessing dose–response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity
暂无分享,去创建一个
[1] C. Dolea,et al. World Health Organization , 1949, International Organization.
[2] Taisen Iguchi,et al. A path forward in the debate over health impacts of endocrine disrupting chemicals , 2014, Environmental Health.
[3] Laura N. Vandenberg,et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. , 2013, Reproductive toxicology.
[4] W. Waddell. History of dose response. , 2010, The Journal of toxicological sciences.
[5] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[6] C. Hughes,et al. An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment , 2005, Environmental health perspectives.
[7] Åke Bergman,et al. State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .
[8] John R. Bucher,et al. Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.
[9] C Sonnenschein,et al. The two faces of janus: sex steroids as mediators of both cell proliferation and cell death. , 2001, Journal of the National Cancer Institute.
[10] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.
[11] J. Sutcliffe,et al. Cell-specific effects of thyroid hormone on RC3/neurogranin expression in rat brain. , 1996, Endocrinology.
[12] Sharon Munn,et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. , 2013, Chemosphere.
[13] J. Katzenellenbogen,et al. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor. , 2008, Biochemistry.
[14] Nicolas Fossat,et al. Purkinje cells and Bergmann glia are primary targets of the TRα1 thyroid hormone receptor during mouse cerebellum postnatal development , 2014, Development.
[15] J. Haseman,et al. Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. , 2002, Environmental health perspectives.
[16] Julie E Goodman,et al. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? , 2012, Regulatory toxicology and pharmacology : RTP.
[17] R. Zoeller,et al. Effects and predicted consequences of persistent and bioactive organic pollutants on thyroid function. , 2013 .
[18] Kristina A Thayer,et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.
[19] R. Zoeller,et al. Endocrine disruption for endocrinologists (and others). , 2006, Endocrinology.
[20] P. Hunt,et al. Invalid Controls Undermine Conclusions of FDA Studies. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[21] T J Woodruff,et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. , 2012, Endocrinology.
[22] John Peterson Myers,et al. A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.
[23] John Peterson Myers,et al. Good Laboratory Practices Are Not Synonymous with Good Scientific Practices, Accurate Reporting, or Valid Data , 2010, Environmental health perspectives.
[24] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[25] D. Carpenter. Effects of Persistent and Bioactive Organic Pollutants on Human Health , 2013 .
[26] Laura N. Vandenberg,et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.
[27] T. Woodruff,et al. Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.
[28] Laura N. Vandenberg,et al. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[29] A. Ismail,et al. Nuclear hormone receptor degradation and gene transcription: An update , 2005, IUBMB life.
[30] Claude Emond,et al. Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment , 2015, Environmental Health.
[31] L. Birnbaum. Environmental Chemicals: Evaluating Low-Dose Effects , 2012, Environmental health perspectives.
[32] Anna Beronius,et al. Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.
[33] Frederick S vom Saal,et al. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. , 2006, Endocrinology.
[34] R. Zoeller,et al. Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. , 2011, Endocrinology.